The latest biotech to roll out of Third Rock Ventures is working on Fc-based therapeutics it hopes could offer new treatment options to patients with autoimmune disorders like Graves' disease.
privacy policy | terms of use | contact us | advertise | pharma blogs | facebook | twitter
Copyright © 2025,